Answers are grounded in this paper and cite their sources.
CI-1040 was well tolerated at 800 mg BID administered with food. Both target suppression and antitumor activity were demonstrated in this phase I study.
No takes yet. Share an insight, caveat, or question.
LoRusso et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: